Designated by the National Association of Epilepsy Centers with its highest distinction level as a level 4 center, the Stanford Comprehensive Epilepsy Program is ranked among the top comprehensive centers in the nation.
Our nationally-recognized epilepsy team works together to develop a personalized treatment plan for you and provides care for more than 4,000 patients annually. Team members include epileptologists, epilepsy surgeons, neuroradiologists, neuropsychologists, neuropsychiatrists and nurses with extensive expertise in epilepsy.
The Stanford Comprehensive Epilepsy Program offers leading-edge epilepsy brain surgery techniques.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
For your convenience, you may check in for all same-day appointments at the Stanford Neuroscience Health Center through a centralized, check-in desk near the front lobby. In addition to all outpatient services, you also can access onsite pre-surgery consultations at the center.
Stanford Health Care is known worldwide for the advanced patient care provided by its doctors and staff. We also provide a wide range of guest services and amenities to our patients and visitors. Learn more about preparing for a hospital stay, billing and financial services, and our other support programs in Patients & Visitors.
Stanford Health Care provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
HOW TO REFER
Patients with difficult to treat epilepsy should be referred to a comprehensive epilepsy center for advanced diagnostic and treatment options. To refer a patient, fax a referral form to 650-725-0390.
Patients with intractable epilepsy who have tried at least two different antiepileptic medications, but still suffer from seizures that affect their quality of life.
Patients who have disabling side effects from their seizure medicines.
Pregnant women with epilepsy or women with epilepsy who wish to become pregnant.
Patients with severe co-morbidities of epilepsy.
Patients who are difficult to diagnose or who may have one of the many imitators of epilepsy.
Any patient who might be a candidate for resective surgery or neuro-implantation to treat their epilepsy.
Track your patients' progress and communicate with Stanford providers securely online.